20 Sep 2017 16:25
20 September 2017
Dechra® Pharmaceuticals PLC
(Dechra or the Company)
Notification and public disclosure of transactions by
persons discharging managerial responsibilities (PDMRs)
Sale of shares:
Dechra Pharmaceuticals PLC announces that on 19 September 2017, Ian Page and Tony Griffin sold the shares set out below. The shares were acquired pursuant to the Dechra Pharmaceuticals PLC Long Term Incentive Plan exercise announced on 19 September 2017. Ian Page sold shares to fund the tax liability arising on the exercise, and Tony Griffin sold all the shares he acquired.
Name | Capacity | Shares Sold | Sale Price per share
| Total beneficial shareholding following this announcement | Percentage of issued share capital
|
Ian Page
| Director/PDMR | 54,910 | £20.23917 | 737,232 | 0.789% |
Tony Griffin | Director/PDMR | 29,937 | £20.23917 | 64,320 | 0.069%
|
The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.
Notification of Dealing Form
1. | Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA") | ||
a) | Name | Ian Page
| |
2. | Reason for the notification | ||
a) | Position/status | Director/PDMR
| |
b) | Initial notification/ amendment | Initial Notification | |
3. | Details of the Issuer | ||
a) | Name | Dechra Pharmaceuticals PLC | |
b) | LEI code | N/A
| |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument
Identification code | Ordinary Shares of 1 pence each
ISIN: GB0009633180 | |
b) | Nature of the transaction | Partial sale of shares obtained under the Company's Long Term Incentive Plan to satisfy tax liability
| |
c) | Price(s) and volumes(s) | Price(s) £20.23917 | Volume(s) 54,910 |
d) | Aggregated information - Aggregate volume - Price |
54,910
£1,111,332.82 | |
e) | Date of the transaction | 2017.09.19 | |
f) | Place of the transaction | London Stock Exchange | |
1. | Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA") | ||
a) | Name | Tony Griffin
| |
2. | Reason for the notification | ||
a) | Position/status | Director/PDMR
| |
b) | Initial notification/ amendment | Initial Notification | |
3. | Details of the Issuer | ||
a) | Name | Dechra Pharmaceuticals PLC | |
b) | LEI code | N/A | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument
Identification code | Ordinary Shares of 1 pence each
ISIN: GB009633180 | |
b) | Nature of the transaction | Sale of shares obtained under the Company's Long Term Incentive Plan
| |
c) | Price(s) and volumes(s) | Price(s) £20.239137 | Volume(s) 29,937 |
d) | Aggregated information - Aggregate volume - Price |
29,937
£605,899.04 | |
e) | Date of the transaction | 2017.09.19 | |
f) | Place of the transaction | London Stock Exchange | |
For further information, please contact:
Melanie Hall, Company Secretary
Telephone number: 01606 814730
About Dechra
Dechra is an international specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.